Colin MD Broom insider trades: Nabriva Therapeutics (NBRV) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Colin reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 2, 2022 | NBRV | ↓ Sell | 5,339 | $0.19 | $1K | Direct | Aug 4, 2022 (2d) |
| Aug 2, 2021 | NBRV | ↓ Sell | 531 | $1.20 | $637 | Direct | Aug 4, 2021 (2d) |
| Aug 20, 2020 | NBRV | ↓ Sell | 11,064 | $0.65 | $7K | Direct | Aug 21, 2020 (1d) |
| Aug 30, 2019 | NBRV | ↑ Buy | 10,177 | $2.03 | $21K | Direct | Sep 3, 2019 (4d) |
| Jun 22, 2018 | NBRV | ↑ Buy | 5,000 | $3.72 | $19K | Direct | Jun 25, 2018 (3d) |
| May 23, 2018 | NBRV | ↑ Buy | 10,000 | $4.60 | $46K | Direct | May 23, 2018 (0d) |
| Sep 22, 2017 | NBRV | ↑ Buy | 2,588 | $8.35 | $22K | Direct | Sep 26, 2017 (4d) |
| Feb 7, 2013 | NPSP | ↓ Sell | 6,100 | $8.74 | $53K | Direct | Feb 11, 2013 (4d) |
| Dec 24, 2012 | VPHM | ↓ Sell | 17,500 | $22.53 | $394K | Direct | Dec 27, 2012 (3d) |
| Dec 10, 2012 | VPHM | ↓ Sell | 74,999 | $24.07 | $1.8M | Direct | Dec 12, 2012 (2d) |
| Dec 14, 2011 | VPHM | ↓ Sell | 50,000 | $25.34 | $1.3M | Direct | Dec 15, 2011 (1d) |
| Dec 13, 2011 | VPHM | ↓ Sell | 40,000 | $23.50 | $940K | Direct | Dec 14, 2011 (1d) |
| Nov 7, 2011 | VPHM | ↓ Sell | 20,000 | $21.00 | $420K | Direct | Nov 8, 2011 (1d) |
| Nov 1, 2011 | VPHM | ↓ Sell | 44,616 | $20.22 | $902K | Direct | Nov 2, 2011 (1d) |
| Sep 13, 2010 | VPHM | ↓ Sell | 30,000 | $13.26 | $398K | Direct | Sep 13, 2010 (0d) |
| Sep 12, 2008 | VPHM | ↓ Sell | 25,353 | $14.25 | $361K | Direct | Sep 16, 2008 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Colin MD Broom's insider trades
Colin MD Broom is a director at Nabriva Therapeutics (NBRV). Since Sep 12, 2008, Colin has reported 4 open-market purchases worth $107K and 12 sales worth $6.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (41 filings), option exercises (15 filings), other transactions (4 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NBRV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.